Partnering News

07.22.2021

Arvinas And Pfizer Announce Global Collaboration To Develop And Commercialize Protac® Protein Degrader Arv-471

07.08.2021

Collaboration Between Abbvie, Biogen And Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants To Human Health And Disease.

06.30.2021

Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206

06.22.2021

SVI announces collaboration with Pfizer

06.01.2021

IMI SOPHIA PARTNERS WITH MACCABI’S RESEARCH AND INNOVATION CENTER (KSM), PFIZER, AND LAUSANNE UNIVERSITY HOSPITAL TO IMPROVE OBESITY TREATMENT

05.27.2021

RefleXion Announces New Additions to Board of Directors and Appoints Audit Committee Chair

05.26.2021

The Foundation for the NIH Announces a New Research Initiative to Find Integrated Treatments Across Common Metabolic Diseases

05.19.2021

Sosei Heptares announces that the third novel drug candidate from its multi-target drug discovery collaboration with Pfizer has started clinical trials

04.29.2021

Pfizer Ventures' Barbara Dalton Appointed as AMRA Medical's Newest Board Member

04.28.2021

Pfizer Acquires Amplyx Pharmaceuticals

04.14.2021

AMRA Medical Generates Largest Imaging Dataset on Body Composition Profiling

03.17.2021

Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments